Sleep Apnea Linked to Alzheimer's Brain Changes in Healthy Older Adults

This completed clinical trial examined the critical relationship between sleep disordered breathing and Alzheimer's disease risk in cognitively healthy older adults. The study aimed to determine whether sleep breathing problems contribute to brain degeneration or result from it.

Researchers enrolled 235 participants and used advanced brain imaging and spinal fluid analysis to track neurodegeneration markers. The intervention group received continuous positive airway pressure (CPAP) therapy to treat their sleep breathing disorders.

Preliminary findings revealed that sleep disordered breathing was associated with increased cerebrospinal fluid levels of phosphorylated-Tau and total-Tau proteins, which are hallmarks of Alzheimer's pathology. Participants also showed decreased glucose uptake in memory-critical brain regions and reduced brain volume in areas vulnerable to dementia.

The four-year study tracked how CPAP treatment affected cognitive decline and brain health markers over time. By comparing treated and untreated groups, researchers could better understand whether improving sleep breathing patterns slows neurodegeneration processes.

These findings have profound implications for longevity and brain health optimization. The research suggests that sleep disorders may be modifiable risk factors for dementia, rather than just consequences of brain aging. Early identification and treatment of sleep breathing problems could potentially delay or prevent Alzheimer's disease onset, offering a practical intervention for maintaining cognitive function throughout aging.